The exorbitant cost of attending JPMorgan — from hotels and flights to coffee and meeting space — has long been a talking point for biopharma execs gathering in San Francisco every January. But as the industry’s signature networking confab fades out, the age-old question is once again in focus: Is it all worthwhile?
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,